CyaA binding to murine cell lines is blocked by anti-CD11b mAb. Cells were preincubated at 4°C for 15 min with or without 20 μg/ml of specific mAbs and then incubated at 4°C for 20 min with 5 μg/ml CyaA and 10 μg/ml of corresponding mAbs. Surface-bound CyaA was detected with biotinylated anti-CyaA polyclonal Abs, revealed by streptavidin-PE, and analyzed by flow cytometry on living cells. (a–c) Fluorescence histograms of D1 dendritic cells were preincubated with medium alone (a), with M1/70 anti-CD11b mAb (b), or with an isotype-matched rat IgG2b (c) and then incubated with (gray) or without (white) CyaA in the presence or absence of mAbs. The cell number is plotted against the log of PE fluorescence. (d–f) D1 dendritic cells (d), FSDCs (e), or J774A.1 macrophages (f) were preincubated with medium alone (○) or with M1/70 anti-CD11b mAb (•), and then incubated with CyaA with or without M1/70 anti-CD11b mAb. Bmax was determined by fitting experimental points to ΔMFI = Bmax × [CyaA]/(Kd + [CyaA]). Binding of CyaA is plotted as a percentage of Bmax plotted against CyaA concentration. (g–i) Effect of specific mAbs on the binding of a fixed dose of CyaA. D1 (g), FSDCs (h), or J774A.1 (i) cells were preincubated with or without specific mAbs (anti-CD11a, 2D7, anti-CD11b, M1/70 or 5C6, anti-CD11c, HL3, anti-CD18, C17/16, control A95-1), and incubated with CyaA at the fixed concentration of 5 μg/ml. Values of ΔMFI obtained for CyaA binding on cells treated with specific mAbs were normalized as a percentage of the ΔMFI values obtained for CyaA binding without mAb.